CIR.L Regulatory News (CIR)

CIR.L Information

There is currently no data for CIR

REMOVE ADS

Additional Listing

19 Mar 2014 08:00

RNS Number : 6176C

Circassia Pharmaceuticals Plc

19 March 2014

Circassia Pharmaceuticals plc (the "Company")

Additional Listing

Application has been made to the UK Listing Authority and the London Stock Exchange for a Block Listing of 2,600,000 ordinary shares of 0.08 pence each under the Circassia EMI Share Option Scheme, to trade on the Main Market of the London Stock Exchange and to be admitted to the Official List of the UK Listing Authority.

These shares will rank equally with the existing issued ordinary shares of the Company.

Enquiries

For further information please contact:

Circassia	+44 (0)1865 405560
Julien Cotta, Company Secretary

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISGGUGUWUPCGMR

Date		Source	Headline
8th Jul 2019	5:02 pm	RNS	Holding(s) in Company
5th Jul 2019	12:07 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:56 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:56 pm	RNS	Holding(s) in Company
2nd Jul 2019	5:55 pm	RNS	Holding(s) in Company
1st Jul 2019	4:55 pm	RNS	Holding(s) in Company
28th Jun 2019	7:00 am	RNS	Total Voting Rights
25th Jun 2019	4:57 pm	RNS	Block Listing Application
17th Jun 2019	4:35 pm	RNS	Price Monitoring Extension
7th Jun 2019	6:00 pm	RNS	Holding(s) in Company
7th Jun 2019	4:18 pm	RNS	Result of AGM
6th Jun 2019	6:23 pm	RNS	Holding(s) in Company
6th Jun 2019	4:11 pm	RNS	Holding(s) in Company
31st May 2019	7:00 am	RNS	Total Voting Rights
28th May 2019	5:58 pm	RNS	Holding(s) in Company
28th May 2019	5:56 pm	RNS	Holding(s) in Company
21st May 2019	9:05 am	RNS	Holding(s) in Company
14th May 2019	4:24 pm	RNS	Annual report and notice of AGM
8th May 2019	7:00 am	RNS	Publication of Tudorza Phase IV ASCENT in JAMA
3rd May 2019	2:18 pm	RNS	Issue of Equity
1st May 2019	7:00 am	RNS	Final Results
30th Apr 2019	7:00 am	RNS	Total Voting Rights
15th Apr 2019	11:55 am	RNS	Holding(s) in Company
1st Apr 2019	7:00 am	RNS	FDA approval of Duaklir for treatment of COPD
29th Mar 2019	4:40 pm	RNS	Second Price Monitoring Extn
29th Mar 2019	4:35 pm	RNS	Price Monitoring Extension
29th Mar 2019	3:58 pm	RNS	FDA website posts Duaklir NDA approval
29th Mar 2019	3:34 pm	RNS	Circassia announces FDA approval of Tudorza sNDA
29th Mar 2019	7:00 am	RNS	Total Voting Rights
5th Mar 2019	4:53 pm	RNS	Holding(s) in Company
4th Mar 2019	4:04 pm	RNS	Holding(s) in Company
28th Feb 2019	7:00 am	RNS	Total Voting Rights
11th Feb 2019	5:17 pm	RNS	Holding(s) in Company
8th Feb 2019	9:00 am	RNS	Notice of Results
6th Feb 2019	4:44 pm	RNS	Holding(s) in Company
6th Feb 2019	7:00 am	RNS	Holding(s) in Company
4th Feb 2019	5:57 pm	RNS	Holding(s) in Company
4th Feb 2019	8:06 am	RNS	Successful FDA Presubmission Meeting for AirNOvent
4th Feb 2019	8:06 am	RNS	Admission to AIM
1st Feb 2019	4:36 pm	RNS	Price Monitoring Extension
1st Feb 2019	4:03 pm	RNS	Holding(s) in Company
31st Jan 2019	7:00 am	RNS	Total Voting Rights
30th Jan 2019	5:30 pm	RNS	Circassia Pharmaceuticals
30th Jan 2019	4:41 pm	RNS	Second Price Monitoring Extn
30th Jan 2019	4:35 pm	RNS	Price Monitoring Extension
28th Jan 2019	3:30 pm	RNS	Holding(s) in Company
28th Jan 2019	3:30 pm	RNS	Holding(s) in Company
25th Jan 2019	11:49 am	RNS	Holding(s) in Company
24th Jan 2019	7:00 am	RNS	Commercial rights acquired from AIT Therapeutics
18th Jan 2019	2:22 pm	RNS	Block listing Interim Review

Latest Share Chat

CIR.L Regulatory News (CIR)

Additional Listing

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending